Sysmex adds FDA-cleared CellaVision DC-1 to portfolio

Create PDF

Nov. 20, 2020—Sysmex America has added the FDA 510(k)-cleared CellaVision DC-1 to its portfolio of CellaVision products for low-volume hematology labs.

The CellaVision DC-1 eliminates the majority of manual steps done traditionally by lab technicians who perform blood cell differentials and standardizes differential results by automating cell location and preclassification.